HHS Temporarily Authorizes Compounding of Unapproved Peptides

• The Department of Health and Human Services has issued a policy allowing compounding pharmacies to manufacture some peptide products.
• This policy is a temporary measure while the agency works on a formal rule change.
• The move is supported by RFK Jr. and is part of the Make America Healthy Again movement.
• The FDA had advised against the policy, expressing concerns over the safety and efficacy of these unapproved peptides.
• The temporary authorization covers six specific peptides.